Danish drugmaker Novo Nordisk has partnered Emcure Pharmaceuticals to commercialise Poviztra, a 2.4 milligram (mg) ...
Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible ...
After a few months on fat jabs such as Wegovy or Mounjaro, the feeling of suppression can start to wane and weight loss can ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...
According to Pharmarack, unlike the previous two years where October sales for Oral Rehydration Solutions (ORS) is lesser ...
Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...
The collaboration gives Emcure exclusive rights to distribute and commercialise semaglutide for chronic weight management in India.
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback